To view the PDF file, sign up for a MySharenet subscription.

YORK TIMBER HOLDINGS LIMITED - Audited summarised consolidated financial results for the year ended 30 June 2016

Release Date: 27/09/2016 16:27
Code(s): YRK     PDF:  
Wrap Text
Audited summarised consolidated financial results for the year ended 30 June 2016

York Timber Holdings Limited

Incorporated in the Republic of South Africa

Registration number: 1916/004890/06

JSE share code: YRK ISIN: ZAE000133450

York, the Company or the Group



Audited summarised consolidated financial results 

for the year ended 30 June 2016



www.york.co.za



Highlights

– Revenue up 15%

– EBITDA increased to R243 million as a result of improved product 

mix, plant efficiencies and with an increase in lumber market share 

of 4%

– Cash generated from operations of R285 million up R102 million from 

prior year

– R283 million invested in the Plywood Expansion Project and 

mechanised harvesting equipment

– Net biological asset value increased by 9% to R2.334 billion

– Underlying TNAV up 13% to 834 cents per share

– Earnings per share increased by 135%

– Core earnings per share increased by 63%

– York returned value to shareholders through a share repurchase 

programme



Commentary



Group performance and financial review

York is celebrating its 100-year anniversary of incorporation, with 

the additional milestone of being listed on the Johannesburg Stock 

Exchange for 70 years.



York's revenue grew by 15% and operating profit by 27%, while cash 

flow from operations improved by R102 million compared to the 

previous year. Growth in lumber and plywood sales were achieved 

despite a weak market. The continued focus on improving value 

creation from raw material has enabled the processing plants to 

absorb log price increases of up to 17% for certain log classes.



The Processing division has improved its profitability by 28% 

year-on-year supported by a recovery of the lumber price index. 

The Forestry division benefitted from the higher log prices with 

profitability increasing by 8% over the previous year. The Wholesale 

division has grown its revenue by 16% and profitability by 322% 

compared to the prior year.



York has further invested in EBITDA-generating capabilities during 

the year and concluded the Plywood Expansion Project and the 

mechanised harvesting in the Highveld forestry region. The benefit 

of these investments will start to materialise in the next financial 

year.



York’s business is based on six strategic pillars namely: lumber, 

plywood, forestry, wholesale, remanufacturing and energy. York will 

continue to invest in these value adding opportunities.



An EBITDA result of R243 million was achieved compared to 

R199 million in the prior year.



Processing division

Total sawmilling intake was consistent year-on-year, with the plywood 

plant intake lower by ca. 5% as a direct consequence of construction 

interruptions. Overall, sawmill recovery increased by 0.5% and costs 

were optimised with increases of less than inflation. York's 

annualised lumber market share increased by 4% year-on-year, in line 

with its focused marketing strategy. The Plywood Expansion Project 

is in the commissioning phase and will be in full production by 

December 2017.



Forestry division

York applies an internationally recognised log paying capability 

model to determine log prices for internal use. These prices are 

weighted with externally procured logs to determine the prices 

charged to processing plants and to value the biological asset. Log 

prices increased on a weighted average basis by 10% during the year.



Site-genotype forestry regimes, site specie-matching and the progress 

to precision forestry practises resulted in an increase in projected 

yields. The forecast volume at maturity, as used in the discounted 

cash flow model, increased by 11.3% or an incremental 2.6 million m3 

year-on-year.



The value of the biological asset increased by R194 million to 

R2,334 billion (based on a post-tax discounted cash flow model).



Investment in fire-preventative measures has continued and minimal 

losses were experienced during the reporting period. Pest and disease 

control measures improved and are mitigated across property 

boundaries.



Wholesale division

York expanded its distribution network throughout Southern Africa. 

The remanufacturing plant is expanding its product range and market 

share. By adding value to timber products, it gives York access to a 

broader customer base.



Balance sheet movements

York invested R283 million in property, plant and equipment, the bulk 

related to the Plywood Expansion Project and the mechanised 

harvesting project in the Highveld district. This was funded by a 

term loan provided from the Land Bank and asset backed facility from 

Absa Bank Limited ("Absa"). Long-term debt increased by R151 million, 

with financial gearing remaining at 19%.



Working capital reduced by R57.1 million as finished goods inventory 

was reduced over the period.  The Company contributed R7.5 million 

towards the self- insurance fund for plantation fire risk. The value 

of the fund was R19.3 million at year-end. York is insured against 

plantation fire risk for up to R100 million for a single event. York 

claimed R30 million for the Taurus plantation fire that occurred in 

the previous financial year.



Underlying tangible net asset value (UTNAV)

UTNAV represents the net asset value, including property plant and 

equipment, biological assets and all other assets less all 

liabilities, but excluding goodwill and the deferred tax on the 

biological asset. This measurement aims to demonstrate the actual 

value inherent in the Company on a per share basis. The UTNAV 

increased by 13% from 739 cents per share to 834 cents per share.



As at 30 June 2016, York shares traded at a 70% discount to the 

UTNAV. York repurchased 13.1 million shares to date under the share 

repurchase programme.



Earnings per share and core earnings per share

In terms of IAS 41, a biological asset must be valued at each 

reporting date and any changes in the valuation are reflected in the 

income statement. York’s biological asset is valued over a 25-year 

lifecycle, considering all the investment costs to maturity. Core 

earnings represent headline earnings adjusted for the change in the 

value of the biological asset, net of tax, as reflected in the income 

statement.



For the period under review, core earnings per share increased from 

19 cents per share to 31 cents per share, an increase of 63%. 

Earnings per share (including the biological asset fair value 

movement) increased from 31 cents per share to 73 cents per share, 

an increase of 135%.



Cash flow

Cash generated from operations improved to R285 million compared to 

R183 million in the previous year. York invested R283 million 

(2015: R203 million) in property, plant and equipment. Hedging 

foreign exchange liabilities resulted in a R7 million cash inflow to 

the Company. Net cash flow from financing activities resulted in a 

net cash inflow of R126 million (previous year R165 million). The 

year-end cash position was R286 million, an increase of

R94 million year-on-year. Interest on cash invested of R11.8 million 

was received during the year (2015: R3.6 million).



Outlook

York's strategy is based on value creation through optimisation to 

unlock appeal to shareholders. This is supported by a strong balance 

sheet and good cash generation. The Plywood Expansion Project was the 

first major investment in executing the growth strategy. The value of 

this investment is still to be realised. York submitted a binding bid 

under the expedited window 4b as part of the Renewable Energy 

Independent Power Producer Procurement Programme and is awaiting 

preferred bidder announcement by Government. This investment will 

allow York to extract more value from its raw material. If this bid 

is unsuccessful, York will pursue the upgrade of its sawmills and 

further invest in remanufacturing capabilities.



In addition, York is well positioned to explore cross-border 

opportunities and potential international investments.





Consolidated statement of financial position

                                          Audited           Audited

                                            As at             As at

                                          30 June           30 June

                                             2016              2015

                                            R'000             R'000

Assets

Non-current assets

Biological asset (note 5)                1 993 501        1 821 029

Investment property                         26 231           21 895

Property, plant and equipment              852 096          628 112

Goodwill                                   565 442          565 442

Intangible assets                            1 632            2 711

Other financial assets                      19 387           41 900

Deferred tax                                 3 039            7 050

Total non-current assets                 3 461 328        3 088 139

Current assets

Biological asset (note 5)                  340 826          319 038

Inventories                                239 459          258 332

Trade and other receivables                233 699          213 742

Cash and cash equivalents                  286 144          192 068

Total current assets                     1 100 128          983 180

Total assets                             4 561 456        4 071 319

Equity and liabilities

Equity

Share capital                               15 908           16 377

Share premium                            1 471 038        1 495 561

Reserves                                        91              732

Retained income                          1 145 536          907 324

Total equity                             2 632 573        2 419 994

Liabilities

Non-current liabilities

Cash-settled share-based payments            3 191           12 538

Deferred tax                               687 332          605 605

Loans and borrowings                       803 546          679 655

Provisions                                  13 114           12 371

Retirement benefit obligations              24 010           22 829

Total non-current liabilities            1 531 193        1 332 998

Current liabilities

Current tax payable                              2               79

Loans and borrowings                        91 949           65 210

Cash-settled share-based payments            3 369            2 386

Operating lease liability                       80              540

Trade and other payables                   302 290          250 112

Total current liabilities                  397 690          318 327

Total liabilities                        1 928 883        1 651 325

Total equity and liabilities             4 561 456        4 071 319





Consolidated statement of comprehensive income

                                          Audited           Audited

                                       Year ended        Year ended

                                          30 June           30 June

                                             2016              2015

                                            R'000             R'000

Revenue                                 1 771 049         1 543 149

Cost of sales                          (1 270 483)       (1 138 734)

Gross profit                              500 566           404 415

Other operating income                     17 970            29 618

Selling, general and administration 

expenses                                 (335 603)         (290 012)

Operating profit                          182 933           144 021

Fair value adjustments                    195 337            42 422

Bargain purchase on acquisition                 -             6 244

Profit before finance costs               378 270           192 687

Investment income                          11 762             3 585

Finance costs                             (56 632)          (58 385)

Profit before taxation                    333 400           137 887

Taxation                                  (95 188)          (36 419)

Profit for the period                     238 212           101 468

Other comprehensive (loss)/income:

Remeasurement of defined benefit 

liability                                    (890)            1 944

Taxation related to components of 

other comprehensive income                    249              (544)

Other comprehensive (loss)/income for the

period net of taxation                       (641)            1 400

Total comprehensive income                237 571           102 868

Basic earnings per share (cents) 

(note 7)                                       73                31





Consolidated statement of cash flows

                                          Audited           Audited

                                       Year ended        Year ended

                                          30 June           30 June

                                             2016              2015

                                            R'000             R'000

Cash generated from operations            284 963           182 574

Investment income                          11 762             3 585

Finance costs                             (56 632)          (58 385)

Taxation paid                             (14 987)           (7 193)

Net cash from operating activities        225 106           120 581

Cash flows applied to investing 

activities

Purchase of property, plant and 

equipment                                (283 241)         (203 288)

Purchase of intangible assets              (1 874)           (1 417)

Acquisition of subsidiaries net 

of cash acquired                                -            (2 769)

Repayment of loans from Group companies      (155)                -

Purchase of financial assets               (7 550)          (17 750)

Sale of financial assets                   30 063            14 314

Purchase of biological assets              (1 384)                -

Sale of biological assets                       -             5 477

Proceeds from disposal of property, 

plant and equipment                           288             1 374

Proceeds from disposal of 

intangible assets                               -                41

Net cash applied to investing 

activities                               (263 853)         (204 018)

Cash flows from financing activities

Reduction of share capital or buyback 

of shares                                 (24 992)           (9 976)

Net movement in loans and borrowings      150 785           175 017

Net cash from financing activities        125 793           165 041

Total cash movement for the period         87 046            81 604

Cash at the beginning of the period       192 068           110 464

Effect of exchange rate movement 

on cash balances                            7 030                 -

Cash at the end of the period             286 144           192 068





Consolidated statement of changes in equity



                                    Defined    Avail-

                                    benefit      able      Re-

                 Share       Share     plan  for-sale   tained      Total

               capital     premium  reserve   reserve   income     equity

Audited          R’000       R’000    R’000     R’000    R’000      R’000



Balance as at 

1 July 2014     16 562   1 505 352     (668)        -  805 856  2 327 102

Profit for

the year             –           –        –         –  101 468    101 468

Other comprehen-

sive income          -           -    1 400         -        -      1 400

Total comprehen-

sive income

for the year         –           –    1 400         -  101 468    102 868

Purchase of

own shares        (185)     (9 791)       -         -        -     (9 976)

Balance as 

at 30 June

2015            16 377   1 495 561      732         -  907 324  2 419 994

Profit for

the period           –           –        –         –  238 212    238 212

Other               

comprehen-

sive income          -           -     (641)        -        -       (641)

Total comprehen-

sive income for 

the period and 

total transactions

with owners          –           –     (641)        -   238 212   237 571

Purchase of

own shares        (469)    (24 523)       -         -         -   (24 992)

Balance as 

at 30 June

2016            15 908   1 471 038       91         - 1 145 536 2 632 573



Notes to the consolidated annual financial statements



1. Basis of preparation

These summarised consolidated annual financial statements have been 

prepared in accordance with the JSE Limited Listings Requirements, 

the Companies Act of South Africa, 71 of 2008, and the Companies 

Regulations, 2011. The Group has applied the recognition and 

measurement requirements of International Financial Reporting 

Standards (IFRS), the SAICA Financial Reporting Guides, as issued by 

the Accounting Practices Committee, and Financial Reporting 

Pronouncements, as issued by the Financial Reporting Standards Council, 

as well as the presentation and disclosure requirements of International 

Accounting Standard (IAS) 34 Interim Financial Reporting. The financial 

results have been compiled under the supervision of JPF van Buuren CA (SA), 

the Chief Financial Officer. The directors take responsibility for the 

preparation of the summarised consolidated annual financial statements and 

for the correct extraction of the financial information.



These summarised results do not include all the information required 

for full annual financial statements, and should be read in 

conjunction with the audited consolidated annual financial statements 

as at and for the year ended 30 June 2016, which are available on the 

Company’s website, www.york.co.za or from the Company’s registered office.



The auditor, KPMG Inc., has issued an opinion on the Group's consolidated 

annual financial statements for the year ended 30 June 2016. The audit was 

conducted in accordance with International Standards on Auditing. The 

auditor issued an unmodified audit opinion. The auditor’s report does not 

necessarily report on all of the information contained in this announcement. 

Shareholders are therefore advised that, in order to obtain a full 

understanding of the nature of the auditor’s engagement, they should obtain 

a copy of the auditor’s report together with the accompanying financial 

information from the issuer’s registered office. These summarised 

consolidated annual financial statements have been extracted from audited 

information, but are not audited. These summarised consolidated annual 

financial results have been prepared on the going concern basis and were

approved by the board of directors ("Board") on 23 September 2016.



There have been no material changes to judgements or estimates 

relating to amounts reported in prior reporting periods.



The Group financial results are presented in Rand, which is the 

Company’s functional currency. All financial information presented 

has been rounded to the nearest thousand.



The significant accounting policies and methods of computation are 

consistent in all material respects with those applied during 

the year ended 30 June 2015, except for the new standards that 

became effective during this year.



2. Additional disclosure items

                                            Audited           Audited

                                         Year ended        Year ended

                                            30 June           30 June

                                               2016              2015

                                              R'000             R'000

Authorised capital commitments

- Contracted, but not provided               59 229           124 034

- Not contracted                             32 112             8 097

Capital expenditure                         283 241           203 288

Depreciation of property, plant 

and equipment                                56 344            54 264

Amortisation of intangible assets             1 079             1 104

Impairment of trade receivables                (335)           (2 233)



– The Group did not have any litigation settlements during the 

reporting period.

– The Group participated in a pooled banking facility of R105 million, 

granted by FirstRand Bank Limited. Group companies provided 

cross-suretyship limited to R5 million in favour of FirstRand Bank 

Limited in respect of their obligations to the bank. The Group did 

not have any other contingent liabilities at the reporting date. The 

security was returned on 11 July 2016 and Absa became the new 

transactional banking partner.

– The Group did not have any covenant defaults or breaches of its 

loan agreements during the period under review or at the reporting 

date.

– No events have occurred between the reporting date and the date of 

release of these results which require adjustment of or disclosure in 

these results.

– No movement occurred in the number of shares issued during the 

period under review, although the Company repurchased 9.4 million 

shares through a subsidiary company within the Group.



3. Comparative figures

The summarised consolidated annual financial statements for the year 

ended 30 June 2015 are presented as published.



4. Operating segments

The Group has three reportable segments, which are the Group’s 

strategic divisions. The Group operates in one geographic segment, 

namely countries within the Southern Africa Development Community 

(SADC).



The segmental analysis is as follows: 

                          Processing

                              plants   Wholesale   Forestry       Total

2016

Revenue: external sales    1 226 743     464 958     77 519   1 770 220

Revenue: inter-segment

sales                        204 926           -    646 253     851 179

Total revenue              1 432 669     464 958    723 772   2 621 399

Depreciation and

amortisation                 (47 964)     (1 419)    (7 732)    (57 115)

Reportable segment profit*   124 152      17 171    100 879     242 202

Capital expenditure          286 306       1 088     62 371     349 765

2015

Revenue: external sales    1 079 157     400 399     62 833   1 542 389

Revenue: inter-segment

sales                        206 763           -    603 115     809 878

Total revenue              1 285 920     400 399    665 948   2 352 267

Depreciation and

amortisation                 (44 402)     (1 424)    (6 005)    (51 831)

Reportable segment profit*    97 026       4 065     93 131     194 222

Capital expenditure          182 542         407     10 850     193 799



*Being the earnings before interest, taxation, depreciation and 

amortisation (EBITDA)





Reconciliation of reportable segment profit or loss

                                            Audited           Audited

                                            30 June           30 June

                                               2016              2015

                                              R'000             R'000

Total EBITDA for reportable segments        242 202           194 222

Depreciation, amortisation and impairment   (57 115)          (51 831)

Unallocated amounts                          (2 154)            1 630

Operating profit                            182 933           144 021



5. Biological asset

                                            Audited           Audited

                                            30 June           30 June

                                               2016              2015

                                              R'000             R'000

Reconciliation of biological asset

Opening balance                           2 140 067         2 103 092

Fair value adjustment

– Increase due to growth 

and enumerations                            329 011           435 042

– Adjustment to standing timber 

values to reflect fair value 

at year-end                                 189 821           (68 958)

Decrease due to harvesting                 (325 956)         (323 632)

Purchased plantations                         1 384                 -

Sale of plantations                               -            (5 477)

Closing balance                           2 334 327         2 140 067

Classified as non-current assets          1 993 501         1 821 029

Classified as current assets                340 826           319 038



                                            Audited           Audited

                                            30 June           30 June

                                               2016              2015

Risk-free rate (R186 bond)                     8.80%             8.28%

Beta factor                                    1.12              1.09

Cost of equity                                15.96%            15.28%

Pre-tax cost of debt                          10.50%            10.25%

Debt: equity ratio                            35:65             35:65

After-tax weighted average cost of capital    13.02%            12.51%



The additional key assumptions underlying the discounted cash flow 

valuation have been updated as follows:

– Volumes: Forecast volumes were updated at the reporting date using 

a merchandising model. Growth in the DCF model refers to the forecast 

yield of planted trees at maturity and has increased from the prior 

year due to the temporary unplanted areas decreasing slightly during 

the year, the expected yield per hectare increasing with improvements 

/amendments to the forestry regime.

– Log prices: The price per cubic metre is based on current and 

future expected market prices per log class. It was assumed that log 

prices will increase at 6.5% per year over the next year, 6% over the 

following year and at 6% over the long term* (2015: 6.5% over the 

first two years and 6% over the long term).

– Operating costs: The costs are based on the unit costs of the 

forest management activities required to enable the trees to reach 

the age of felling.



The costs include the current and future expected costs of 

harvesting, maintenance and risk management, as well as an 

appropriate amount of fixed overhead costs. A contributory asset 

charge takes into account the cost of property, plant and equipment 

utilised to generate cash flows from the biological asset over the 

valuation period. The operating costs exclude the transport costs 

necessary to get the asset to market. These operating costs have

been reviewed and updated to current actual costs. A long-term 

inflation rate of 6.15% in year one, 6% in year two and 6% over the 

long term* (2015: 5.7% in year one, 6% in year two and 6% over the 

long term) was used.



(*Management believes that, as a result of the anticipated shortage 

in local log supply and forecast long-term demand, long-term revenue 

inflation will be greater than cost inflation.)



6. Related parties

The Group’s related parties are its subsidiaries and key management, 

including directors. No change in control occurred in the Company’s 

subsidiaries during the period.



7. Earnings per share

The calculation of basic earnings per share is based on:

                                            Audited           Audited

                                            30 June           30 June

                                               2016              2015

Basic earnings attributable to ordinary

shareholders (R’000)                        238 212           101 468

Weighted average number of ordinary 

shares in issue (’000)                      325 286           327 544

Earnings per share (cents)                       73                31



No change occurred in the number of shares in issue and no instruments 

had a dilutive effect.



8. Headline earnings per share

The calculation of headline earnings per share is based on:

                                            Audited           Audited

                                            30 June           30 June

                                               2016              2015

                                              R'000             R'000

Reconciliation of basic earnings to 

headline earnings

Basic earnings attributable to ordinary

shareholders                                238 212           101 468

(Profit)/loss on sale of assets and 

liabilities (net of tax)                        161              (304)

Fair value adjustment on investment 

property (net of tax)                        (1 910)               24

Impairment of plant, equipment and 

vehicles (net of tax)                         1 729                 -

Bargain purchase on acquisition                   -            (6 244)

Headline earnings for the year              238 192            94 944

Weighted average number of ordinary 

shares in issue (’000)                      325 286           331 032

Headline earnings per share (cents)              73                29



9. Core earnings per share

The calculation of core earnings per share is based on:

                                            Audited           Audited

                                            30 June           30 June

                                               2016              2015

                                              R'000             R'000

Headline earnings attributable to 

ordinary shareholders                       238 192            94 944

Fair value adjustment on biological 

assets (net of tax)                        (138 870)          (30 566)

Core earnings for the year                   99 322            64 378

Weighted average number of ordinary 

shares in issue (’000)                      325 286           331 032

Core earnings per share (cents)                  31                19



10. Board of directors

There were no changes to the Board during the year.



Company information

Executive directors: Pieter van Zyl (CEO), Pieter van Buuren (CFO)



Non-executive directors: Dr Jim Myers* (Non-executive Chairman, USA), 

Paul Botha, Dr Azar Jammine*, Shakeel Meer, Dinga Mncube*,

Thabo Mokgatlha*, Maserame Mouyeme*, Gavin Tipper* 

(*independent) 



Registered office: York Corporate Office: 3 Main Road, Sabie, 

Mpumalanga. Postal address: PO Box 1191, Sabie 1260



Auditors: KPMG Inc.



Company secretary: Han-hsiu Hsieh



Chief Financial Officer: Pieter van Buuren



Sponsor: One Capital



Transfer secretaries: Computershare Investor Services (Pty) Ltd



27 September 2016


Date: 27/09/2016 04:27:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story